Literature DB >> 18475407

Trichomonas vaginalis Weakens human Amniochorion in an in vitro model of premature membrane rupture.

D Draper1, W Jones, R P Heine, M Beutz, J I French, J A McGregor.   

Abstract

OBJECTIVE: Trichomonas vaginalis (TV) infection is associated with preterm rupture of membranes (PROM) and preterm birth. We evaluated the effects of TV growth and metabolism on preparations of human amniochorion to understand and characterize how TV may impair fetal-membrane integrity and predispose to PROM and preterm birth.
METHODS: Term fetal membranes were evaluated using an established in vitro fetal-membrane model. Fresh TV clinical isolates were obtained from pregnant women. The protozoa (5.0x10(5) to 1.5x10(6)/ml) were incubated with fetal membranes in modified Diamond's medium for 20 h at 37 degrees C in 5% CO2.The effects of fetal-membrane strength (bursting tension, work to rupture, and elasticity) were measured using a calibrated Wheatstone-bridge dynamometer. Tests were also performed to evaluate the effects of 1) inoculum size; 2) metronidazole (50 microg/ml); and 3) cell-free filtrate.
RESULTS: The TV-induced membrane effects were 1) isolate variable; 2) inoculum dependent; 3) incompletely protected by metronidazole; and 4) mediated by both live organisms as well as protozoan-free culture filtrates. Six of 9 isolates significantly reduced the calculated work to rupture (P < or = 0.02); 7 of 9 reduced bursting tension; and 1 of 9 reduced elasticity. One isolate significantly increased the work to rupture and bursting tension (P < or = 0.002).
CONCLUSIONS: In vitro incubation of fetal membranes with TV can significantly impair the measures of fetal-membrane strength. This model may be used to delineate the mechanisms of TV-induced membrane damage. This study suggests that there are enzyme-specific effects as well as pH effects.

Entities:  

Year:  1995        PMID: 18475407      PMCID: PMC2364407          DOI: 10.1155/S1064744995000160

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  23 in total

1.  The role of infection in premature rupture of the membranes.

Authors:  I C KNOX; J K HOERNER
Journal:  Am J Obstet Gynecol       Date:  1950-01       Impact factor: 8.661

2.  Protease production by microorganisms associated with reproductive tract infection.

Authors:  J A McGregor; D Lawellin; A Franco-Buff; J K Todd; E L Makowski
Journal:  Am J Obstet Gynecol       Date:  1986-01       Impact factor: 8.661

3.  Isolation of a cell-detaching factor of Trichomonas vaginalis.

Authors:  G E Garber; L T Lemchuk-Favel; W R Bowie
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

4.  Characterization of a secreted cytoactive factor from Trichomonas vaginalis.

Authors:  W B Lushbaugh; A C Turner; G A Gentry; P C Klykken
Journal:  Am J Trop Med Hyg       Date:  1989-07       Impact factor: 2.345

5.  Analysis of the proteinases of representative Trichomonas vaginalis isolates.

Authors:  K A Neale; J F Alderete
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

6.  The effect of Trichomonas vaginalis and the role of pH on cell culture monolayer viability.

Authors:  G E Garber; W R Bowie
Journal:  Clin Invest Med       Date:  1990-04       Impact factor: 0.825

7.  Bacteria and inflammatory cells reduce chorioamniotic membrane integrity and tensile strength.

Authors:  J N Schoonmaker; D W Lawellin; B Lunt; J A McGregor
Journal:  Obstet Gynecol       Date:  1989-10       Impact factor: 7.661

8.  Collagen content of human amniotic membranes: effect of gestation length and premature rupture.

Authors:  S J Skinner; G A Campos; G C Liggins
Journal:  Obstet Gynecol       Date:  1981-04       Impact factor: 7.661

9.  Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; D E Yerg; D H Martin; D A Eschenbach
Journal:  Obstet Gynecol       Date:  1991-12       Impact factor: 7.661

10.  Antibody in sera of patients infected with Trichomonas vaginalis is to trichomonad proteinases.

Authors:  J F Alderete; E Newton; C Dennis; K A Neale
Journal:  Genitourin Med       Date:  1991-08
View more
  7 in total

1.  TaqMan-based detection of Trichomonas vaginalis DNA from female genital specimens.

Authors:  J A Jordan; D Lowery; M Trucco
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 2.  Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies.

Authors:  Jenell S Coleman; Charlotte A Gaydos; Frank Witter
Journal:  Obstet Gynecol Surv       Date:  2013-01       Impact factor: 2.347

3.  The Marine Biological Laboratory (Woods Hole) and the scientific advancement of women in the early 20th century: the example of Mary Jane Hogue (1883-1962).

Authors:  Steven J Zottoli; Ernst-August Seyfarth
Journal:  J Hist Biol       Date:  2015       Impact factor: 1.326

Review 4.  Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.

Authors:  R Matthew Chico; Daniel Chandramohan
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-07-07       Impact factor: 4.481

5.  Pathogenesis to treatment: preventing preterm birth mediated by infection.

Authors:  J A McGregor; J I French
Journal:  Infect Dis Obstet Gynecol       Date:  1997

6.  Genital infections and risk of premature rupture of membranes in Mulago Hospital, Uganda: a case control study.

Authors:  Sarah Nakubulwa; Dan K Kaye; Freddie Bwanga; Nazarius Mbona Tumwesigye; Florence M Mirembe
Journal:  BMC Res Notes       Date:  2015-10-16

7.  Proton pump inhibitors are associated with a reduced likelihood for sexually transmitted diseases in women in the emergency department.

Authors:  Johnathan Michael Sheele; Nathan Morris; Donald Byars; Frank Counselman
Journal:  Indian J Sex Transm Dis AIDS       Date:  2017 Jan-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.